XML 13 R6.htm IDEA: XBRL DOCUMENT v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:        
Net loss $ (3,933) $ (17,459) $ (74,588) $ (35,170)
Adjustments to reconcile net loss to net cash used in operating activities:        
Non-cash lease expense     255 232
Accretion of investment discounts     (934) (1,375)
Stock-based compensation 1,924 2,428 7,280 7,986
Change in fair value of warrant liabilities (17,025) (564) 11,560 (22,917)
Changes in operating assets and liabilities:        
Prepaid expenses and other assets     (1,549) 540
Accounts payable, accrued expenses and other liabilities     (6,028) 2,686
Operating lease liabilities     (265) (232)
Net cash used in operating activities     (64,269) (48,250)
Cash flows from investing activities:        
Purchase of available-for-sale short-term investments     (68,755) (91,909)
Proceeds from maturities of available-for-sale short-term investments     117,278 123,164
Net cash provided by investing activities     48,523 31,255
Cash flows from financing activities:        
Proceeds from exercise of common stock warrants     390  
Payment of taxes withheld on issuance of restricted stock units     (903)  
Proceeds from exercise of stock options     333 115
Net cash (used in) provided by financing activities     (180) 115
Net change in cash and cash equivalents     (15,926) (16,880)
Cash and cash equivalents at beginning of period     22,808 20,549
Cash and cash equivalents at end of period $ 6,882 $ 3,669 6,882 3,669
Non-cash activities:        
Issuance of common stock in settlement of liability     598  
Settlement of warrant liability     75  
Unrealized loss on available-for-sale securities, net     (150) $ (17)
Series X1 Non-voting Convertible Preferred Stock [Member]        
Non-cash activities:        
Cashless conversion of Series X1 non-voting convertible preferred stock for common stock     $ 16,676